DR. SANDRA G. HASSINK, MD
Medical Practice at Rockland Rd, Wilmington, DE
License number
Delaware C10002168
Category
Medical Practice
Type
Pediatrics
Address
Address
2
1600 Rockland Rd, Wilmington, DE 19803
191 Provider DEPT ENROLLMENT, Rockland, DE 19732
191 Provider DEPT ENROLLMENT, Rockland, DE 19732
Phone
(302) 651-4000
(302) 651-4945 (Fax)
(302) 651-6212
(302) 651-4945 (Fax)
(302) 651-6212
Personal information
See more information about SANDRA G. HASSINK at radaris.comName
Address
Phone
2602 Pennington Dr, Wilmington, DE 19810
2602 Pennington Ct, Wilmington, DE 19810
Organization information
See more information about SANDRA G. HASSINK at bizstanding.comA I Du Pont Hospital-Children - Sandra G Hassink MD
1600 Rockland Rd, Wilmington, DE 19803
Categories:
Pediatrics Physicians & Surgeons, Physicians & Surgeons
Phone:
(302) 651-5936 (Phone)
Nemours Pediatrics - Sandra G Hassink MD
1602 Jessup St, Wilmington, DE 19802
Categories:
Pediatrics Physicians & Surgeons
Phone:
(302) 651-4000 (Phone)
Sandra G Hassink MD
1600 Rockland Rd, Wilmington, DE 19803
Industry:
Medical Doctor's Office
Medical Doctors:
Brian Roberts (Principal),Sandra Gibson Hassink Medical Doctor, inactive
Professional information
Dr. Sandra G Hassink, Wilmington DE - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
Alfred I. duPont Hospital for Children
1600 Rockland Rd, Wilmington 19803
(302) 651-4200 (Phone)
Nemours duPont Pediatrics, St. Francis
700 Clayton St SUITE 400, Wilmington 19805
(302) 421-9700 (Phone), (302) 421-9743 (Fax)
Nemours duPont Pediatrics, Jessup Street
1602 Jessup St, Wilmington 19802
(302) 651-4000 (Phone), (302) 651-4543 (Fax)
1600 Rockland Rd, Wilmington 19803
(302) 651-4200 (Phone)
Nemours duPont Pediatrics, St. Francis
700 Clayton St SUITE 400, Wilmington 19805
(302) 421-9700 (Phone), (302) 421-9743 (Fax)
Nemours duPont Pediatrics, Jessup Street
1602 Jessup St, Wilmington 19802
(302) 651-4000 (Phone), (302) 651-4543 (Fax)
Certifications:
Pediatrics, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Vanderbilt University
Graduated: 1978
St Christophers
Vanderbilt University
Graduated: 1978
St Christophers
Sandra G Hassink, Wilmington DE
Specialties:
Pediatrician
Address:
1600 Rockland Rd, Wilmington, DE 19803
Education:
Vanderbilt University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics
Method For Treating Respiratory Distress Syndrome
US Patent:
6884777, Apr 26, 2005
Filed:
Nov 14, 2000
Appl. No.:
09/711295
Inventors:
Vicky L. Funanage - Wilmington DE, US
Sandra G. Hassink - Wilmington DE, US
Susan M. Kirwin - Thornton PA, US
Darlise O'Connor - Newark DE, US
Sandra G. Hassink - Wilmington DE, US
Susan M. Kirwin - Thornton PA, US
Darlise O'Connor - Newark DE, US
Assignee:
The Nemours Foundation - Wilmington DE
International Classification:
A61K038/19
US Classification:
514 12, 530351
Abstract:
The invention provides a method for treating infants, children or adults suffering from pulmonary distress caused by low or insufficient production of surfactant. It is particularly suitable for treating premature infants suffering from Respiratory Distress Syndrome. The method comprises administering a leptin compound to an individual with impaired surfactant production for a time and in an amount sufficient to enhance surfactant production. The method may be used for treatment of any mammal with impaired lung surfactant production.
Method For Treating Respiratory Distress Syndrome
US Patent:
2006008, Apr 20, 2006
Filed:
Apr 25, 2005
Appl. No.:
11/113311
Inventors:
Vicky Funanage - Wilmington DE, US
Sandra Hassink - Wilmington DE, US
Susan Kirwin - Thornton PA, US
Darlise O'Connor - Newark DE, US
Sandra Hassink - Wilmington DE, US
Susan Kirwin - Thornton PA, US
Darlise O'Connor - Newark DE, US
International Classification:
A61K 38/17
US Classification:
514012000
Abstract:
The invention provides a method for treating infants, children or adults suffering from pulmonary distress caused by low or insufficient production of surfactant. It is particularly suitable for treating premature infants suffering from Respiratory Distress Syndrome. The method comprises administering a leptin compound to an individual with impaired surfactant production for a time and in an amount sufficient to enhance surfactant production. The method may be used for treatment of any mammal with impaired lung surfactant production.